Organ-on-a-Chip Technology

Technology set to transform pre-clinical drug testing and disease modelling, accelerating the delivery of safer, more effective therapies for all

Bioengineers at Queen Mary are leading development of organ-on-a-chip technology through The Queen Mary, Centre for Bioengineering and the Centre for Predictive in vitro Models

An organ-on-a-chip is a bioengineered microfluidic device in which the different types of living cells found within an organ are grown together. Within these devices,  key physical, chemical and biological aspects of the living organ are recreated in order to recapitulate in vivo behaviour.

Our multidisciplinary researcher teams are developing organ-on-a-chip models for a wide variety of tissues/organs and different disease conditions including: osteoarthritis, cardiovascular disease, kidney disease, inflammation and various cancers. 

We work closely with key partners in the biopharma industry, organ-chip technology providers, regulatory authorities and other stakeholders, helping to drive technology translation and shape policy. We welcome new stakeholder partners to contact us and join our affiliates club

What we are showing at the event: Our interactive stand allows visitors to see real cells within an organ-chip and have a go at preparing a chip. Come and meet some of our researchers, working with industry to develop next generation organ-chip models for condtions including bone metastasis, cardiovascular disease, osteoarthritis and inflammation.

emulate chip
Organ-chip (Emulate S1)
gut chip
Microscopy image of cells with the gut organ-chip

Collaborate with us:

We welcome industry and other non-academic stake holders to join our affiliates club at the Centre for Predictive in vitro Models and Centre for Bioengineering 

Contact: Prof Thomas IskratschProf Hazel ScreenProf Martin KnightDr Stefaan Verbruggen